Target Eye Drops Maximum Redness Relief Eye

NDC 11673-100 · Target Corporation

Generic nameGlycerin, Naphazoline hydrochloride

Dosage formSOLUTION/ DROPS

RouteOPHTHALMIC

Active ingredient(s)GLYCERIN, NAPHAZOLINE HYDROCHLORIDE

Strength500; 30 mg/100mL; mg/100mL

Pharmacologic classAllergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]

Marketing categoryOTC MONOGRAPH DRUG

Packages

11673-100-01 — 1 BOTTLE, DROPPER in 1 BOX (11673-100-01) / 15 mL in 1 BOTTLE, DROPPER

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0496-0980 — lidocaine and glycerin, 0573-0554 — Glycerin, Lidocaine, Phenylephrine Hydrochloride, 0573-2843 — Glycerin, Lidocaine, Petrolatum, and Phenylephrine Hydrochloride, 0573-2868 — glycerin, petrolatum, phenylephrine HCl, pramoxine HCl, 10157-2126 — WHITE PETROLATUM, GLYCERIN, PRAMOXINE HYDROCHLORIDE, and PHENYLEPHRINE HYDROCHLORIDE, 10157-4103 — GLYCERIN and LIDOCAINE, 10742-8141 — Naphazoline hydrochloride, Polysorbate 80, 10742-8142 — Naphazoline hydrochloride, Polysorbate 80, 10742-8158 — Naphazoline hydrochloride, Polysorbate 80, 10742-8160 — Naphazoline hydrochloride, Povidone, Propylene glycol, 11673-430 — Pheniramine Maleate and Naphazoline Hydrochloride, 11716-0365 — carboxymethylcellulose sodium, glycerin, 11822-0011 — lubricant eye drops, 11822-0552 — Pheniramine Maleate and Naphazoline Hydrochloride, 11822-1067 — Glycerin, Hypromellose, Polyethylene glycol 400, 11822-2944 — glycerin, phenylephrine HCl, pramoxine HCl, white petrolatum, 11822-3312 — Glycerin, 11822-3321 — Glycerin, 11822-9100 — Glycerin Suppository, 11822-9101 — Glycerin Suppository, +299 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels